Interact to see
Advertisement
Advertisement
DOXGX vs PXIIX
DOXGX vs PXIIX Comparison
Open Charts DOXGX vs PXIIX
Virtus KAR Equity Income I
Price$22.58
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets136.51M
DOXGX vs PXIIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
DOXGX has more cash in the bank: 116B vs. PXIIX (137M). PXIIX pays higher dividends than DOXGX: PXIIX (2.83) vs DOXGX (1.43). DOXGX was incepted earlier than PXIIX: DOXGX (3 years) vs PXIIX (18 years). PXIIX (1.11) is less costly to investors than DOXGX (0.46). PXIIX is a more actively managed with annual turnover of: 17.00 vs. DOXGX (15.00). DOXGX has a lower initial minimum investment than PXIIX: DOXGX (2500) vs PXIIX (100000). PXIIX annual gain was more profitable for investors over the last year : 11.56 vs. DOXGX (5.29).
| DOXGX | PXIIX | DOXGX / PXIIX | |
| Total Expense Ratio | 0.41 | 0.95 | 43% |
| Annual Report Gross Expense Ratio | 0.46 | 1.11 | 41% |
| Fund Existence | 3 years | 18 years | - |
| Gain YTD | 9.064 | 11.948 | 76% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 116B | 137M | 84,672% |
| Annual Yield % from dividends | 1.43 | 2.83 | 51% |
| Returns for 1 year | 5.29 | 11.56 | 46% |
| Returns for 3 years | 34.21 | 25.04 | 137% |
| Returns for 5 years | N/A | 9.10 | - |
| Returns for 10 years | N/A | 57.69 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 23.44 | 0.21 | +0.90% |
| Saratoga Health & Biotechnology I | |||
| ETLNX | 15.55 | N/A | N/A |
| Eventide Large Cap Focus N | |||
| EKBCX | 14.76 | -0.02 | -0.14% |
| Allspring Diversified Cap Bldr C | |||
| GCVAX | 25.09 | -0.04 | -0.16% |
| Goldman Sachs Large Cp Val Insghts A | |||
| OTCNX | 80.12 | -0.18 | -0.22% |
| Invesco Discovery Large Cap R | |||